Retatrutide – 15mg

Retatrutide – 15mg
Triple Hormone Receptor Agonist (GLP-1 / GIP / Glucagon)

Biovexa Retatrutide is a multi-pathway peptide investigated as a next-generation tri-agonist of the GLP-1, GIP and glucagon receptors. It is used in studies of metabolic signalling, energy expenditure, glycaemic regulation and appetite pathways.

Key research focus: Metabolic signalling, energy expenditure, glycaemic regulation, appetite pathways.

Form: Lyophilized powder — ≥99% purity (HPLC)
Content: 15mg per 3ml vial
Storage: Store at 2–8 °C, protected from light
Origin: Made in USA

For research use only. Not for human or animal consumption. Not a drug, food, supplement or cosmetic, and not intended to diagnose, treat, cure or prevent any disease. Qualified researchers only. See our Research Use Policy.